Jean C. Grégoire

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean‐Claude Tardif, Simon Kouz, David D. Waters et al. · New England Journal of Medicine · 2019 · 2.8K citations · Full text

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Nadia Bouabdallaoui, Jean‐Claude Tardif, David D. Waters et al. · European Heart Journal · 2020 · 299 citations · Full text

Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction

Jean‐Claude Tardif, Jean-François Tanguay, Scott Wright et al. · Journal of the American College of Cardiology · 2013 · 205 citations · Full text

Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

Jean‐Claude Tardif, Éric Rhéaume, Louis‐Philippe Lemieux Perreault et al. · Circulation Cardiovascular Genetics · 2015 · 183 citations

Treatment With 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients With Recent Acute Coronary Syndrome

Jean‐Claude Tardif, Philippe L. L’Allier, Réda Ibrahim et al. · Circulation Cardiovascular Imaging · 2010 · 154 citations